Literature DB >> 21446007

Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities.

Kailash C Chadha1, Bindukumar B Nair, Srikant Chakravarthi, Rita Zhou, Alejandro Godoy, James L Mohler, Ravikumar Aalinkeel, Stanley A Schwartz, Gary J Smith.   

Abstract

BACKGROUND: Prostate specific antigen (PSA) is a well known biomarker for early diagnosis and management of prostate cancer. Furthermore, PSA has been documented to have anti-angiogenic and anti-tumorigenic activities in both in vitro and in vivo studies. However, little is known about the molecular mechanism(s) involved in regulation of these processes, in particular the role of the serine-protease enzymatic activity of PSA.
METHODS: Enzymatic activity of PSA isolated directly from seminal plasma was inhibited specifically (>95%) by incubation with zinc2+ . Human umbilical vein endothelial cells (HUVEC) were utilized to compare/contrast the physiological effects of enzymatically active versus inactive PSA.
RESULTS: Equimolar concentrations of enzymatically active PSA and PSA enzymatically inactivated by incubation with Zn2+ had similar physiological effects on HUVEC, including inhibiting the gene expression of pro-angiogenic growth factors, like VEGF and bFGF, and up-regulation of expression of the anti-angiogenic growth factor IFN-γ; suppression of mRNA expression for markers of blood vessel development, like FAK, FLT, KDR, TWIST-1; P-38; inhibition of endothelial tube formation in the in vitro Matrigel Tube Formation Assay; and inhibition of endothelial cell invasion and migration properties. DISCUSSION: Our data provides compelling evidence that the transcriptional regulatory and the anti-angiogenic activities of human PSA are independent of the innate enzymatic activity.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21446007      PMCID: PMC4498389          DOI: 10.1002/pros.21385

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  54 in total

1.  Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas.

Authors:  R Stege; M Grande; K Carlström; B Tribukait; A Pousette
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

2.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

3.  Prostate specific antigen (PSA) in breast and ovarian cancer.

Authors:  E Kucera; C Kainz; C Tempfer; R Zeillinger; H Koelbl; G Sliutz
Journal:  Anticancer Res       Date:  1997 Nov-Dec       Impact factor: 2.480

4.  Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.

Authors:  A Magklara; A Scorilas; C Stephan; G O Kristiansen; S Hauptmann; K Jung; E P Diamandis
Journal:  Urology       Date:  2000-09-01       Impact factor: 2.649

5.  Two step procedure for purification of enzymatically active prostate-specific antigen from seminal plasma.

Authors:  B Bindukumar; Elzbieta Kawinski; Craig Cherrin; Leah M Gambino; Madhavan P N Nair; Stanley A Schwartz; Kailash C Chadha
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-12-25       Impact factor: 3.205

6.  Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.

Authors:  H Yu; M A Levesque; G M Clark; E P Diamandis
Journal:  Clin Cancer Res       Date:  1998-06       Impact factor: 12.531

7.  Recombinant prostate specific antigen inhibits angiogenesis in vitro and in vivo.

Authors:  A H Fortier; J W Holaday; H Liang; C Dey; D K Grella; J Holland-Linn; H Vu; S M Plum; B J Nelson
Journal:  Prostate       Date:  2003-08-01       Impact factor: 4.104

8.  VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.

Authors:  Hans-Peter Gerber; Ajay K Malik; Gregg P Solar; Daniel Sherman; Xiao Huan Liang; Gloria Meng; Kyu Hong; James C Marsters; Napoleone Ferrara
Journal:  Nature       Date:  2002-06-27       Impact factor: 49.962

9.  Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid.

Authors:  J P Kavanagh
Journal:  J Reprod Fertil       Date:  1985-09

10.  Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis.

Authors:  Liang Hu; Jennifer M Roth; Peter Brooks; Joanna Luty; Simon Karpatkin
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

View more
  3 in total

1.  Androgen receptors expressed by prostatic stromal cells obtained from younger versus older males exhibit opposite roles in prostate cancer progression.

Authors:  You-Yi Lu; Bo Jiang; Fu-Jun Zhao; Di Cui; Qi Jiang; Jun-Jie Yu; En-Hui Li; Xiao-Hai Wang; Bang-Min Han; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2013-06-24       Impact factor: 3.285

2.  Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application.

Authors:  Ruth A Fuhrman-Luck; Daniela Loessner; Judith A Clements
Journal:  EJIFCC       Date:  2014-10-24

Review 3.  KLK3 in the Regulation of Angiogenesis-Tumorigenic or Not?

Authors:  Hannu Koistinen; Jaana Künnapuu; Michael Jeltsch
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.